Immunohistochemical pitfalls in the demonstration of insulin-degrading enzyme in normal and neoplastic human tissues

Previously, we have identified the cytoplasmic zinc metalloprotease insulin-degrading enzyme(IDE) in human tissues by an immunohistochemical method involving no antigen retrieval (AR) by pressure cooking to avoid artifacts by endogenous biotin exposure and a detection kit based on the labeled streptavidin biotin (LSAB) method. Thereby, we also employed 3% hydrogen peroxide(H2O2) for the inhibition of endogenous peroxidase activity and incubated the tissue sections with the biotinylated secondary antibody at room temperature (RT). We now add the immunohistochemical details that had led us to this optimized procedure as they also bear a more general relevance when demonstrating intracellular tissue antigens. Our most important result is that endogenous peroxidase inhibition by 0.3% H2O2 coincided with an apparently positive IDE staining in an investigated breast cancer specimen whereas combining a block by 3% H2O2 with an incubation of the biotinylated secondary antibody at RT, yet not at 37 degrees Celsius, revealed this specimen as almost entirely IDE-negative. Our present data caution against three different immunohistochemical pitfalls that might cause falsely positive results and artifacts when using an LSAB- and peroxidase-based detection method: pressure cooking for AR, insufficient quenching of endogenous peroxidases and heating of tissue sections while incubating with biotinylated secondary antibodies.

💡 Research Summary

The paper revisits the immunohistochemical (IHC) detection of insulin‑degrading enzyme (IDE), a cytoplasmic zinc metalloprotease, and identifies three methodological pitfalls that can generate false‑positive staining when using a labeled streptavidin‑biotin (LSAB) system coupled with peroxidase detection. The authors previously reported a reliable protocol that omitted antigen retrieval (AR) by pressure cooking, employed a strong endogenous peroxidase block (3 % H₂O₂), and incubated the biotinylated secondary antibody at room temperature (RT). In the current work they detail how each of these steps was optimized and why they matter for intracellular antigens in general.

First, they demonstrate that pressure‑cooking for AR, a common step to unmask epitopes, actually exposes endogenous biotin in tissue sections. Because the LSAB method relies on streptavidin‑biotin binding, this exposure creates non‑specific binding sites that amplify the diaminobenzidine (DAB) chromogen, producing artifactual IDE positivity. By completely omitting the pressure‑cooking step, the authors avoid this source of background.

Second, they compare two concentrations of hydrogen peroxide used to quench endogenous peroxidase activity: 0.3 % (the conventional concentration) and 3 % (a more aggressive block). In a breast cancer specimen, the lower concentration failed to fully inhibit peroxidase, resulting in a spurious IDE signal. The higher concentration eliminated the background staining, revealing that the tumor was essentially IDE‑negative. This finding underscores that insufficient peroxidase quenching is a major source of false positivity in LSAB‑peroxidase protocols.

Third, the temperature at which the biotinylated secondary antibody is incubated proves critical. Incubation at 37 °C for 30 minutes or longer markedly increased non‑specific binding, again leading to an apparent IDE signal. In contrast, incubation at RT for the same duration preserved specificity, allowing only true IDE‑expressing cells to be visualized.

Combining these observations, the authors propose a refined IHC workflow for IDE and, by extension, other intracellular antigens: (1) omit heat‑based antigen retrieval; (2) block endogenous peroxidase with 3 % H₂O₂; (3) perform secondary antibody incubation at RT; and (4) consider using polymer‑based detection systems that bypass the streptavidin‑biotin interaction to further reduce background.

The study’s broader impact lies in its systematic dissection of how three seemingly minor technical choices can interact to generate misleading results. By providing concrete experimental evidence, the authors give the pathology and research communities a clear set of best‑practice guidelines that improve the reliability of LSAB‑based IHC, especially when investigating cytoplasmic proteins like IDE. Their work encourages investigators to critically evaluate antigen retrieval, peroxidase quenching, and incubation temperature in any LSAB‑peroxidase assay, thereby enhancing reproducibility and diagnostic accuracy.